Carugo, Alessandro
https://orcid.org/0000-0001-5182-3320
Mayo Clinic
The University of Texas MD Anderson Cancer Center
Citations 1
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism
Peng, David H. , Kundu, Samrat T. , Fradette, Jared J. , Diao, Lixia , Tong, Pan, Byers, Lauren A. , Wang, Jing , Canales, Jaime Rodriguez, Villalobos, Pamela, Mino, Barbara , Yang, Yanan , Minelli, Rosalba, Peoples, Michael , Bristow, Christopher A. , Heffernan, Timothy P. , Carugo, Alessandro , Wistuba, Ignacio I. , Peoples, Michael D , Gibbons, Don L , Yang, Yanan
Science Translational Medicine | March 13, 2019 | Volume: 11 | Issue: 483 | Pages: No page available
Suppression of ZEB1 through miR-200 expression or HDAC inhibition with mocetinostat sensitizes resistant KRAS mutant lung cancers to MEK inhibition.